ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

ABSTRACT Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused
on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and …

A number of countries now include meningococcal vaccines in their routine immunization
programs. This review focuses on different approaches to including meningococcal vaccines …

Abstract The Global Meningococcal Initiative (GMI) was established in 2009 and comprises
an international team of scientists, clinicians, and public health officials with expertise in …

The Global Meningococcal Initiative (GMI) is composed of an international group of
scientists, clinicians and public health officials with expertise in meningococcal immunology …

Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …

As reviewed in this paper, meningococcal disease epidemiology varies substantially by
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …

Africa historically has had the highest incidence of meningococcal disease with high
endemic rates and periodic epidemics. The meningitis belt, a region of sub-Saharan Africa …

Invasive meningococcal disease (IMD) is a serious disease that is fatal in 5–15% and
disabling in 12–20% of cases. The dynamic and unpredictable epidemiology is a particular …

Abstract Background In 2010–2017, meningococcal serogroup A conjugate vaccine (MACV)
was introduced in 21 African meningitis belt countries. Neisseria meningitidis A epidemics …